MIRA MIRA Pharmaceuticals, Inc.

Fundamentals / CIK 0001904286 / USD

MIRA Pharmaceuticals, Inc. reported $7.27M in total assets and a net loss of $9.76M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MIRA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$0$0$0-$11.20MFY 2022 Net Income: -$7.06M2022FY 2023 Net Income: -$11.98M2023FY 2024 Net Income: -$7.85M2024FY 2025 Net Income: -$10.44M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $1.72M $3.31M $1.57M $2.35M
Total Operating Expenses $10.49M $8.02M $8.53M $7.05M
Interest Expense -- -$166K $3.46M $10K
Net Income -$10.44M -$7.85M -$11.98M -$7.06M
Basic EPS -$1.35 -$0.51 -$0.85 -$0.53
Diluted EPS -$1.35 -$0.51 -$0.85 -$0.53
Basic Shares Outstanding 23.7M 15.4M 13.9M 13.2M
Diluted Shares Outstanding -- 15.4M 13.9M 13.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $947K $706K $525K $497K $413K $496K $314K $861K
Total Operating Expenses $1.41M $1.16M $1.10M $5.82M $1.32M $1.55M $1.81M $2.44M
Interest Expense -- -- -- -- -- -- -$21K -$38K
Net Income -$1.42M -$1.21M -$1.15M -$5.98M -$1.14M -$1.54M -$1.78M -$2.40M
Basic EPS -- -$0.03 -$0.03 -- -$1.18 -$0.09 -$0.11 --
Diluted EPS -$0.03 -$0.03 -$0.03 -- -$1.18 -$0.09 -$0.11 --
Basic Shares Outstanding 42.0M 42.0M 41.9M -- 19.3M 17.0M 16.6M --
Diluted Shares Outstanding -- -- -- -- 19.3M 17.0M 16.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $6.35M $2.83M $4.60M $351K
Short-Term Investments $4.68M -- -- --
Cash & Short-Term Investments $11.03M $2.83M $4.60M $351K
Accounts Receivable, Net -- $5.0K $5.0K --
Total Current Assets $11.06M $2.89M $4.86M $494K
Total Non-Current Assets $35K $35K $74K $364K
Total Assets $11.09M $2.92M $4.93M $858K
Accounts Payable $129K $723K $539K $789K
Other Current Liabilities $573K -- -- --
Total Current Liabilities $702K $723K $558K $1.37M
Total Non-Current Liabilities $0 $0 $0 $84K
Total Liabilities $702K $723K $558K $1.45M
Total Debt (incl. Leases) -- -- $5.1K $84K
Common Stock $4.2K $1.7K $1.5K $6.7K
Retained Earnings -$39.58M -$29.14M -$21.29M -$9.30M
Total Stockholders' Equity $10.39M $2.20M $4.37M -$596K
Total Equity $10.39M $2.20M $4.37M -$596K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $2.50M $3.61M $4.82M $6.35M $2.64M $730K $1.21M $2.83M
Short-Term Investments $4.47M $4.50M $4.59M $4.68M $4.89M -- -- --
Cash & Short-Term Investments $6.97M $8.11M $9.41M $11.03M $7.54M $730K $1.21M $2.83M
Accounts Receivable, Net -- -- -- -- -- -- -- $5.0K
Total Current Assets $7.23M $8.17M $9.43M $11.06M $7.60M $833K $1.36M $2.89M
Total Non-Current Assets $35K $35K $35K $35K $35K $35K $35K $35K
Total Assets $7.27M $8.20M $9.46M $11.09M $7.63M $868K $1.40M $2.92M
Accounts Payable $232K $41K $34K $129K $84K $298K $101K $723K
Other Current Liabilities -- -- -- $573K -- -- -- --
Total Current Liabilities $426K $41K $115K $702K $84K $298K $106K $723K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $426K $41K $115K $702K $84K $298K $106K $723K
Common Stock $4.2K $4.2K $4.2K $4.2K $4.0K $1.7K $1.7K $1.7K
Retained Earnings -$43.36M -$41.94M -$40.73M -$39.58M -$33.60M -$32.46M -$30.92M -$29.14M
Total Stockholders' Equity $6.84M $8.16M $9.35M $10.39M $7.55M $570K $1.29M $2.20M
Total Equity $6.84M $8.16M $9.35M $10.39M $7.55M $570K $1.29M $2.20M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$10.44M -$7.85M -$11.98M -$7.06M
Stock-Based Compensation $6.31M $1.92M $2.55M $1.30M
Change in Receivables -- -- -$12K --
Operating Cash Flow -$4.66M -$5.56M -$4.53M -$5.60M
Common Stock Issued $7.01M $3.61M $7.70M $2.90M
Financing Cash Flow $8.18M $3.79M $8.78M $3.15M
Net Change in Cash $3.51M -$1.77M $4.25M -$2.46M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.42M -$1.21M -$1.15M -$5.98M -$1.14M -$1.54M -$1.78M -$2.40M
Stock-Based Compensation $102K $22K $108K $4.56M $391K $490K $875K $547K
Operating Cash Flow -$1.30M -$1.21M -$1.20M -$1.14M -$1.10M -$800K -$1.63M -$1.81M
Common Stock Issued -- -- -- $3.84M $2.82M $345K $3.4K --
Financing Cash Flow $194K $0 -$331K $4.84M $3.01M $324K $3.4K $493K
Net Change in Cash -$1.10M -$1.21M -$1.53M $3.71M $1.91M -$476K -$1.63M -$1.31M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -100.5% -357.0% -273.9% --
Return on Assets (ROA) -94.1% -268.6% -242.9% -822.6%
Current Ratio 15.75x 3.99x 8.70x 0.36x
Quick Ratio 15.71x 3.92x 8.26x 0.26x
Debt to Equity -- -- 0.00x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -142.7% -116.1% -104.9% -100.5% -90.9% -1362.6% -611.9% -357.0%
Return on Assets (ROA) -134.4% -115.6% -103.6% -94.1% -89.9% -894.3% -565.5% -268.6%
Current Ratio 16.97x 200.08x 82.16x 15.75x 90.53x 2.79x 12.86x 3.99x
Quick Ratio 16.36x 198.75x 81.97x 15.71x 89.79x 2.45x 11.36x 3.92x
Source: SEC EDGAR CompanyFacts (CIK 0001904286) · from March 31, 2022 Data through September 30, 2026 · synced Nov 21, 2026, 05:02 UTC · Open in terminal